Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 1/20 | 0.35 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.32 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.32 |
| ▸ | CCR2 | P41597 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27081629 | 0.97 | BBOX1 (0.36) | BBOX1SHBGCYP1A2CHRNB4CHRNA3 | |
| SCHEMBL815698 | 0.97 | BBOX1 (0.36) | BBOX1SHBGCYP1A2CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL20875141 | 0.95 | BBOX1 (0.35) | BBOX1SHBGCYP1A2CHRNB4CHRNA3 | |
| Iodide SCHEMBL20875143 | 0.95 | BBOX1 (0.35) | BBOX1SHBGCYP1A2CHRNB4CHRNA3 | |
| Bromide SCHEMBL20875136 | 0.95 | BBOX1 (0.35) | BBOX1SHBGCYP1A2CHRNB4CHRNA3 | |
| Fluoride Ion SCHEMBL20875139 | 0.95 | BBOX1 (0.35) | BBOX1SHBGCYP1A2CHRNB4CHRNA3 | |
| SCHEMBL8758451 | 0.95 | BBOX1 (0.38) | BBOX1SHBGCHRNB4CHRNA3CHRNA7 | |
| Bicarbonate SCHEMBL31207716 | 0.84 | BBOX1 (0.50) | BBOX1CCR2 | |
| Sulfuric Acid SCHEMBL31207749 | 0.84 | BBOX1 (0.38) | BBOX1CCR2 | |
| SCHEMBL20797037 | 0.83 | BBOX1 (0.38) | BBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312245-B2 | Method for manufacture of co-crystallized zeolite beta and zeolite mordenite in the presence of ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2025-05-27 | — | — | US | claimed |
| WO-2025102202-A1 | POLYISOCYANATE COMPOSITION, AND COATING LAYER HAVING IMPROVED CHEMICAL RESISTANCE | 万华化学集团股份有限公司 | 2025-05-22 | — | — | WO | claimed |
| CN-119978314-A | Polyisocyanate composition and coating with improved chemical resistance | 万华化学集团股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-11827523-B2 | Method for manufacture of zeolite beta in the presence of ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2023-11-28 | — | — | US | claimed |
| US-20230331565-A1 | METHOD FOR MANUFACTURE OF ZEOLITE BETA IN THE PRESENCE OF ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2023-10-19 | — | — | US | claimed |
| US-20230331563-A1 | METHOD FOR MANUFACTURE OF CO-CRYSTALLIZED ZEOLITE BETA AND ZEOLITE MORDENITE IN THE PRESENCE OF ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2023-10-19 | — | — | US | claimed |
| CN-107899608-B | Preparation method of self-supporting metal modified Beta molecular sieve and application of self-supporting metal modified Beta molecular sieve in synthesis of isoprene | 中国科学院长春应用化学研究所 | 2020-07-28 | — | — | CN | claimed |
| CN-107899608-A | A kind of preparation method of metal-modified Beta molecular sieves of self-supporting and its application in isoprene is synthesized | 中国科学院长春应用化学研究所 | 2018-04-13 | — | — | CN | claimed |
| CN-103601212-B | Method for preparing chiral polymorph A-shaped excessive Beta zeolite molecular sieve | UNIV JILIN | 2015-06-03 | — | — | CN | claimed |
| CN-103601212-A | Method for preparing chiral polymorph A-shaped excessive Beta zeolite molecular sieve | UNIV JILIN | 2014-02-26 | — | — | CN | claimed |
| EP-4748481-A1 | METHOD FOR TREATING EXHAUST GAS | Covestro Deutschland AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260116766-A1 | BETA ZEOLITE AND METHOD FOR MANUFACTURING THE SAME | TOSOH CORPORATION (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4733258-A1 | BETA ZEOLITE AND METHOD FOR MANUFACTURING THE SAME | Tosoh Corporation (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-12522509-B2 | Method to co-synthesize amorphous and crystalline materials in the presence of ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2026-01-13 | — | — | US | disclosed |
| US-12410062-B2 | Method to synthesize crystalline materials in the presence of ODSO with improved zeolite crystallization rates and enhanced relative crystallinity | SAUDI ARABIAN OIL COMPANY (SA) | 2025-09-09 | — | — | US | disclosed |
| EP-0047452-B1 | PROCESS FOR THE PREPARATION OF ISOCYANURATES CONTAINING ISOCYANATE GROUPS THE PRODUCTS OBTAINED BY THE PROCESS AND THEIR APPLICATION AS ISOCYANATE COMPONENT IN POLYURETHANE LACQUERS | BAYER AG (DE) | 1984-03-21 | — | — | EP | disclosed |
| US-4419513-A | FROM HEXAMETHYLENE DIISOCYANATE AND ISOPHOR-ONE DIISOCYANATE | BAYER AKTIENGESELLSCHAFT (DE) | 1983-12-06 | — | — | US | disclosed |
| EP-0047452-A1 | Process for the preparation of isocyanurates containing isocyanate groups the products obtained by the process and their application as isocyanate component in polyurethane lacquers | BAYER AG (DE) | 1982-03-17 | — | — | EP | disclosed |
| EP-0013880-B1 | ISOCYANATE GROUPS-CONTAINING ISOCYANURATES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS ISOCYANATE COMPONENT IN POLYURETHANE LACQUERS | BAYER AG (DE) | 1981-12-30 | — | — | EP | disclosed |
| EP-0013880-A1 | Isocyanate groups-containing isocyanurates, process for their preparation and their application as isocyanate component in polyurethane lacquers | BAYER AG (DE) | 1980-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116766-A1 | BETA ZEOLITE AND METHOD FOR MANUFACTURING THE SAME | SIK1, LBR, MANBA | BBOX1 896/4885SHBG 2126/4885CYP1A2 3928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.